Predictors of survival in patients with locally advanced thymoma and thymic carcinoma (Masaoka stages III and IVa)

European Journal of Cardio-thoracic Surgery

Volumn 37, Issue 4, 2010, Pages 819-823

  Cardillo, Giuseppe ^a   Carleo, Francesco ^a   Giunti, Roberto ^a   Lopergolo, Michele Giovanni ^a   Salvadori, Lorenzo ^a   De Massimi, Alessia Raffaella ^a   Petrella, Lea ^b   Martelli, Massimo ^a  

^a SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Induction therapy; Surgery; Thymic carcinoma; Thymoma

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUORODEOXYGLUCOSE F 18; PREDNISONE;

ADOLESCENT; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ADVANCED CANCER; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; LUNG EMBOLISM; LUNG INFECTION; LUNG LOBECTOMY; MAJOR CLINICAL STUDY; MALE; MASAOKA STAGING SYSTEM; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; THYMECTOMY; THYMIC CARCINOMA; THYMOMA; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; CHEMOTHERAPY, ADJUVANT; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PROGNOSIS; SURVIVAL ANALYSIS; THYMECTOMY; THYMOMA; THYMUS NEOPLASMS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77949658320     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2009.11.001     Document Type: Article

References (24)

1. Johnson S.B., Eng T.Y., Giaccone G., and Thomas Jr. C.R. Thymoma: update for the new millennium. The Oncologist 6 (2001) 239-246
2. Masaoka A., Monden Y., Nakahara K., and Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer 48 (1981) 2485-2492
3. Rosai J. Histological typing of tumors of the thymus. World Health Organization International Histological Classification of Tumors. 2nd ed. (1999), Springer-Verlag, New York, Berlin
4. In: Travis W.D., Brambilla E., Müller-Hermelink H.K., and Harris C.C. (Eds). Pathology and genetics of tumours of the lung, pleura, thymus and heart (WHO classification of tumours) (2004), IARC Press, Lyon, France 145-247
5. Endo M., Nakagawa K., Ohde Y., Okumura T., Kondo H., Igawa S., Nakamura Y., Tsuya A., Murakami H., Takahashi T., Yamamoto N., Ito I., and Kameya T. Utility of 18FDG-PET for differentiating the grade of malignancy in thymic epithelial tumors. Lung Cancer 61 (2008) 350-355
6. Maggi G., Casadio C., Cavallo A., Cianci R., Molinatti M., and Ruffini E. Thymoma: results of 241 operated cases. Ann Thorac Surg 51 (1991) 152-156
7. Blumberg D., Port J.L., Weksler B., Delgado R., Rosai J., Bains M.S., Ginsberg R.J., Martini N., McCormack P.M., Rusch V., and Burt M.E. Thymoma: a multivariate analysis of factors predicting survival. Ann Thorac Surg 60 (1995) 908-914
8. Thomas Jr. C.R., Wright C.D., and Loehrer P.J. Thymoma: a state of the art. J Clin Oncol 17 (1999) 2280-2289
9. Macchiarini P., Chella A., Ducci F., Rossi B., Testi C., Bevilacqua G., and Angeletti C.A. Neoadjuvant chemotherapy, surgery, and postoperative radiation therapy for invasive thymoma. Cancer 68 (1991) 706-713
10. Rea F., Sartori F., Loy M., Calabrò F., Fornasiero A., Daniele O., and Altavilla G. Chemotherapy and operation for invasive thymoma. J Thorac Cardiovasc Surg 106 (1993) 543-549
11. Kim E.S., Putnam J.B., Komaki R., Walsh G.L., Ro J.Y., Shin H.J., Truong M., Moon H., Swisher S.G., Fossella F.V., Khuri F.R., Hong W.K., and Shin D.M. A phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy and consolidation chemotherapy for unresectable malignant thymomas: final report. Lung Cancer 44 (2004) 369-379
12. Singhal S., Shrager J.B., Rosenthal D.I., LiVolsi V.A., and Kaiser L.R. Comparison of stages I-II thymoma treated by complete resection with or without adjuvant radiation. Ann Thorac Surg 76 (2003) 1635-1642
13. Nakagawa K., Asamura H., Matsuno Y., Suzuki K., Kondo H., Maeshima A., Miyaoka E., and Tsuchiya R. Thymoma: a clinicopathologic study based on the new World Health Organization classification. J Thorac Cardiovasc Surg 126 (2003) 1134-1140
14. Giaccone G., Musella R., Berretto O., Donadio M., and Calciati A. Cisplatin-containing chemotherapy in the treatment of invasive thymoma: report of five cases. Cancer Treat Rep 69 (1985) 695-697
15. Venuta F., Rendina E.A., Longo F., De Giacomo T., Anile M., Mercadante E., Ventura L., Osti M.F., Francioni F., and Coloni G.F. Long-term outcome after multimodality treatment for stage III thymic tumors. Ann Thorac Surg 76 (2003) 1866-1872
16. Sung Y.M., Lee K.S., Kim B.T., Choi J.Y., Shim Y.M., and Yi C.A. 18F-FDG PET/CT of thymic epithelial tumors: usefulness for distinguishing and staging tumor subgroups. J Nucl Med 47 (2006) 1628-1634
17. Watanabe M., Takagi K., Aoki T., Ozeki Y., Tanaka S., Kobayashi H., and Aida S. A comparison of biopsy through a parasternal anterior mediastinotomy under local anesthesia and percutaneous needle biopsy for malignant anterior mediastinal tumors. Surg Today 28 (1998) 1022-1026
18. Lucchi M., Melfi F., Dini P., Basolo F., Viti A., Givigliano F., Angeletti C.A., and Mussi A. Neoadjuvant chemotherapy for stage III and IVA thymomas: a single-institution experience with a long follow-up. J Thorac Oncol 1 (2006) 308-313
19. Wright C.D. Pleuropneumonectomy for the treatment of Masaoka stage IVa thymoma. Ann Thorac Surg 82 (2006) 1234-1239
20. Huang J., Rizk N.P., Travis W.D., Seshan V.E., Bains M.S., Dycoco J., Downey R.J., Flores R.M., Park B.J., and Rusch V.W. Feasibility of multimodality therapy including extended resections in stage IVA thymoma. J Thorac Cardiovasc Surg 134 (2007) 1477-1483
21. Regnard J.F., Magdeleinat P., Dromer C., Dulmet E., de Montpreville V., Levi J.F., and Levasseur P. Prognostic factors and long-term results after thymoma resection: a series of 307 patients. J Thorac Cardiovasc Surg 112 (1996) 376-384
22. Lardinois D., Rechsteiner R., Lang R.H., Gugger M., Betticher D., von Briel C., Krueger T., and Ris H.B. Prognostic relevance of Masaoka and Muller-Hermelink classification in patients with thymic tumors. Ann Thorac Surg 69 (2000) 1550-1555
23. Curran W.J., Kornstein M.J., Brooks J.J., and Turrisi III A.T. Invasive thymoma: the role of mediastinal irradiation following complete or incomplete surgical resection. J Clin Oncol 6 (1988) 1722-1727
24. Wright C.D., Choi N.C., Wain J.C., Mathisen D.J., Lynch T.J., and Fidias P. Induction chemoradiotherapy followed by resection for locally advanced Masaoka stage III and IVA thymic tumors. Ann Thorac Surg 85 (2008) 385-389